Order Article Reprints

Amaral C, Correia-da-Silva G, Almeida CF, Valente MJ, Varela C, Tavares-da-Silva E, Vinggaard AM, Teixeira N, Roleira FMF. An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER⁺) Breast Cancer: Effects on Sensitive and Resistant Cell Lines. Molecules. 2023; 28(2):789. https://doi.org/10.3390/molecules28020789

Amaral, Cristina, Georgina Correia-da-Silva, Cristina Ferreira Almeida, Maria João Valente, Carla Varela, Elisiário Tavares-da-Silva, Anne Marie Vinggaard, Natércia Teixeira, and Fernanda M. F. Roleira. 2023. "An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER⁺) Breast Cancer: Effects on Sensitive and Resistant Cell Lines" Molecules 28, no. 2: 789. https://doi.org/10.3390/molecules28020789

Amaral, C., Correia-da-Silva, G., Almeida, C. F., Valente, M. J., Varela, C., Tavares-da-Silva, E., Vinggaard, A. M., Teixeira, N., & Roleira, F. M. F. (2023). An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER⁺) Breast Cancer: Effects on Sensitive and Resistant Cell Lines. Molecules, 28(2), 789. https://doi.org/10.3390/molecules28020789